soramed

Soramed Inc. is a Japanese healthcare technology company dedicated to transforming surgical scheduling in acute care hospitals. Its flagship product, OpePro (patent pending), is an AI SaaS system that addresses the chronic underutilization of operating rooms — Japanese hospital OR utilization averages below 70% — by enabling cross-departmental sharing of open surgical time slots. Traditionally, each clinical department managed its own schedule in isolation, creating invisible gaps that could not be filled. OpePro breaks down these silos by matching available OR slots with pending elective procedures across all specialties, allowing hospitals to advance surgeries sooner and maximize throughput. In 2026, Soramed expanded OpePro with dedicated robotic surgery scheduling features. The company won the Hospital Management Innovation Pitch 2025 award and raised seed funding in October 2025.